Serotonergic receptor subtypes and hallucinogen-induced stimulus control.
More than a quarter century has passed since the demonstration that indoleamine and phenethylamine hallucinogens can function as discriminative stimuli in the rat, and that serotonergic systems are critically involved. During that period our knowledge of the physiology, pharmacology, biochemistry, and molecular biology of serotonergic receptors has increased exponentially; with each advance it has been necessary to reexamine our assumptions regarding hallucinogen-induced stimulus control. Of particular interest is the hypothesis that a drug may act, at a molecular level, upon multiple receptors to produce, at a behavioral level, a compound discriminative stimulus. The salience of the individual elements of such compound stimuli may be influenced by a variety of experimental factors including training dose, pretreatment time, the state of sensitization of the systems being acted upon, and the nature of the drugs chosen for tests of generalization. This article provides examples of experimental approaches to these complexities using selective agonists and antagonists, depletion-induced sensitization, and antagonist correlation analysis.
Winter
J C
JC
Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, 14214-3000, USA.
Fiorella
D J
DJ
Timineri
D M
DM
Filipink
R A
RA
Helsley
S E
SE
Rabin
R A
RA
D000818:Animals; D003463:Cues; D004192:Discrimination, Psychological / Q000187:drug effects*; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D051381:Rats; D011985:Receptors, Serotonin / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000494:pharmacology
D006213:Hallucinogens; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists